These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 38102807

  • 1. Pushing MP2RAGE boundaries: Ultimate time-efficient parameterization combined with exhaustive T1 synthetic contrasts.
    Bapst B, Massire A, Mauconduit F, Gras V, Boulant N, Dufour J, Bodini B, Stankoff B, Luciani A, Vignaud A.
    Magn Reson Med; 2024 Apr; 91(4):1608-1624. PubMed ID: 38102807
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Simultaneous Optimization of MP2RAGE T1 -weighted (UNI) and FLuid And White matter Suppression (FLAWS) brain images at 7T using Extended Phase Graph (EPG) Simulations.
    Dokumacı AS, Aitken FR, Sedlacik J, Bridgen P, Tomi-Tricot R, Mooiweer R, Vecchiato K, Wilkinson T, Casella C, Giles S, Hajnal JV, Malik SJ, O'Muircheartaigh J, Carmichael DW.
    Magn Reson Med; 2023 Mar; 89(3):937-950. PubMed ID: 36352772
    [Abstract] [Full Text] [Related]

  • 4. Optimization of MP2RAGE T1 mapping with radial view-ordering for deep brain stimulation targeting at 7 T MRI.
    Tao S, Zhou X, Lin C, Patel V, Westerhold EM, Middlebrooks EH.
    Magn Reson Imaging; 2023 Jul; 100():55-63. PubMed ID: 36924805
    [Abstract] [Full Text] [Related]

  • 5. Optimization and validation of low-field MP2RAGE T1 mapping on 0.35T MR-Linac: Toward adaptive dose painting with hypoxia biomarkers.
    Park CKS, Warner NS, Kaza E, Sudhyadhom A.
    Med Phys; 2024 Nov; 51(11):8124-8140. PubMed ID: 39140821
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. T1-Based Synthetic Magnetic Resonance Contrasts Improve Multiple Sclerosis and Focal Epilepsy Imaging at 7 T.
    Massire A, Seiler C, Troalen T, Girard OM, Lehmann P, Brun G, Bartoli A, Audoin B, Bartolomei F, Pelletier J, Callot V, Kober T, Ranjeva JP, Guye M.
    Invest Radiol; 2021 Feb 01; 56(2):127-133. PubMed ID: 32852445
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. MP2RAGE for deep gray matter measurement of the brain: A comparative study with MPRAGE.
    Okubo G, Okada T, Yamamoto A, Kanagaki M, Fushimi Y, Okada T, Murata K, Togashi K.
    J Magn Reson Imaging; 2016 Jan 01; 43(1):55-62. PubMed ID: 26032895
    [Abstract] [Full Text] [Related]

  • 10. The Compressed Sensing MP2RAGE as a Surrogate to the MPRAGE for Neuroimaging at 3 T.
    Trotier AJ, Dilharreguy B, Anandra S, Corbin N, Lefrançois W, Ozenne V, Miraux S, Ribot EJ.
    Invest Radiol; 2022 Jun 01; 57(6):366-378. PubMed ID: 35030106
    [Abstract] [Full Text] [Related]

  • 11. CNR improvement of MP2RAGE from slice encoding directional acceleration.
    Shin W, Shin T, Oh SH, Lowe MJ.
    Magn Reson Imaging; 2016 Jul 01; 34(6):779-784. PubMed ID: 26979541
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Optimization of magnetization-prepared 3-dimensional fluid attenuated inversion recovery imaging for lesion detection at 7 T.
    Saranathan M, Tourdias T, Kerr AB, Bernstein JD, Kerchner GA, Han MH, Rutt BK.
    Invest Radiol; 2014 May 01; 49(5):290-8. PubMed ID: 24566291
    [Abstract] [Full Text] [Related]

  • 14. Can 7T MPRAGE match MP2RAGE for gray-white matter contrast?
    Oliveira ÍAF, Roos T, Dumoulin SO, Siero JCW, van der Zwaag W.
    Neuroimage; 2021 Oct 15; 240():118384. PubMed ID: 34265419
    [Abstract] [Full Text] [Related]

  • 15. Fluid and white matter suppression with the MP2RAGE sequence.
    Tanner M, Gambarota G, Kober T, Krueger G, Erritzoe D, Marques JP, Newbould R.
    J Magn Reson Imaging; 2012 May 15; 35(5):1063-70. PubMed ID: 22170818
    [Abstract] [Full Text] [Related]

  • 16. SNR efficiency of combined bipolar gradient echoes: Comparison of three-dimensional FLASH, MPRAGE, and multiparameter mapping with VFA-FLASH and MP2RAGE.
    Jutras JD, Wachowicz K, Gilbert G, De Zanche N.
    Magn Reson Med; 2017 Jun 15; 77(6):2186-2202. PubMed ID: 27416792
    [Abstract] [Full Text] [Related]

  • 17. 7T MPFLAIR versus MP2RAGE for Quantifying Lesion Volume in Multiple Sclerosis.
    Spini M, Choi S, Harrison DM.
    J Neuroimaging; 2020 Jul 15; 30(4):531-536. PubMed ID: 32569408
    [Abstract] [Full Text] [Related]

  • 18. 3D Quantitative Synthetic MRI in the Evaluation of Multiple Sclerosis Lesions.
    Fujita S, Yokoyama K, Hagiwara A, Kato S, Andica C, Kamagata K, Hattori N, Abe O, Aoki S.
    AJNR Am J Neuroradiol; 2021 Mar 15; 42(3):471-478. PubMed ID: 33414234
    [Abstract] [Full Text] [Related]

  • 19. Improved Visualization of Cortical Lesions in Multiple Sclerosis Using 7T MP2RAGE.
    Beck ES, Sati P, Sethi V, Kober T, Dewey B, Bhargava P, Nair G, Cortese IC, Reich DS.
    AJNR Am J Neuroradiol; 2018 Mar 15; 39(3):459-466. PubMed ID: 29439120
    [Abstract] [Full Text] [Related]

  • 20. Blood-brain barrier breakdown in non-enhancing multiple sclerosis lesions detected by 7-Tesla MP2RAGE ΔT1 mapping.
    Choi S, Spini M, Hua J, Harrison DM.
    PLoS One; 2021 Mar 15; 16(4):e0249973. PubMed ID: 33901207
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.